Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $52.4 million.

  • Tandem Diabetes Care's Other Non-Current Liabilities rose 6246.9% to $52.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year increase of 6246.9%. This contributed to the annual value of $32.4 million for FY2024, which is 169.34% up from last year.
  • Tandem Diabetes Care's Other Non-Current Liabilities amounted to $52.4 million in Q3 2025, which was up 6246.9% from $52.1 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Other Non-Current Liabilities registered a high of $52.4 million during Q3 2025, and its lowest value of $17.2 million during Q2 2022.
  • Over the past 5 years, Tandem Diabetes Care's median Other Non-Current Liabilities value was $31.8 million (recorded in 2023), while the average stood at $30.0 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Other Non-Current Liabilities skyrocketed by 6671.58% in 2021 and then tumbled by 4689.38% in 2022.
  • Over the past 5 years, Tandem Diabetes Care's Other Non-Current Liabilities (Quarter) stood at $17.8 million in 2021, then skyrocketed by 34.07% to $23.9 million in 2022, then surged by 33.08% to $31.8 million in 2023, then rose by 1.69% to $32.4 million in 2024, then surged by 61.82% to $52.4 million in 2025.
  • Its last three reported values are $52.4 million in Q3 2025, $52.1 million for Q2 2025, and $37.1 million during Q1 2025.